Skip to main content
. Author manuscript; available in PMC: 2022 May 22.
Published in final edited form as: Womens Health Issues. 2021 Nov 21;32(2):194–202. doi: 10.1016/j.whi.2021.10.007

Table 3.

Change (baseline to post-treatment; and baseline to 3-month follow-up) compared by group.

Change (Baseline to Post-Treatment)
With vs. Without Probable PTSD
Change (Baseline to 3-Month Follow-Up)
With vs. Without Probable PTSD
Mean (95% CI) p-value Mean (95% CI) p-value
Insomnia (ISI Total Score) −2.30
(−4.94, 0.14)
0.064 −2.14
(−5.41, 1.13)
0.20
Sleep Quality (PSQI Total Score) −0.73
(−2.69, 1.23)
0.47 −0.57
(−2.87, 1.73)
0.63
Diary Sleep Efficiency (%) 5.79
(0.11, 11.47)
0.046 5.54
(−0.36, 11.26)
0.066
Diary TST (Minutes) 13.11
(−17.12, 43.33)
0.40 36.79
(3.77, 69.81)
0.029
Objective Sleep Efficiency (%) 0.74
(−2.29, 3.78)
0.63 1.91
(−1.63, 5.46)
0.29
Nightmares Per Week −1.83
(−2.90, −0.77)
0.001 −1.72
(−2.95, −0.49)
0.006
Depression (PHQ-9 Total Score) −1.88
(−4.14, 0.38)
0.10 −1.55
(−3.87, 0.78)
0.19
Anxiety (GAD-7 Total Score) −0.24 0.85
(−2.83, 2.35)
−0.54
(−3.41, 2.32)
0.71
Mental QoL (SF-12 Mental) −0.69
(−5.63, 4.25)
0.79 2.65
(−2.31, 7.60)
0.30
Physical QoL (SF-12 Physical) −0.27
(−4.50, 3.97)
0.90 −0.21
(−4.78, 4.35)
0.93

Note. Tabled values show differences in means with 95% confidence interval for the difference in brackets; p<0.10 reported as 3 digits after the decimal point, p=0.100-.99 reported as 2 digits after decimal point, and values of .000 and 1.0 reported as <0.001 and >0.99.